Literature DB >> 8864627

Interferon-induced vitiligo in a patient with chronic viral hepatitis C infection.

H Simsek1, C Savas, H Akkiz, H Telatar.   

Abstract

Vitiligo is an autoimmune disease characterized by depigmentation of the skin due to destruction of melanocytes. Interferons have been used for the treatment of chronic hepatitis C and some malignancies. We report interferon alpha-2a-induced vitiligo in a male patient with chronic active hepatitis C. All skin lesions disappeared completely without requiring therapy after discontinuation of interferon. This case suggests that vitiligo may be developed during interferon therapy as a side effect.

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8864627     DOI： 10.1159/000246208

Source DB:  PubMed          Journal:  Dermatology        ISSN： 1018-8665            Impact factor:   5.366


  8 in total

1.  Vitiligo improvement in a hepatitis C patient after treatment with PEG-interferon alpha-2a and ribavirin: a case report.

Authors:  M Taffaro; N Pyrsopoulos; H Cedron; E Cacayorin; D Weppler; J Moon; S Nishida; D Levi; T Kato; G Selvaggi; A Tzakis; E Schiff
Journal:  Dig Dis Sci       Date:  2007-04-12       Impact factor: 3.199

Review 2.  Paraneoplastic vitelliform retinopathy: clinicopathologic correlation and review of the literature.

Authors:  Mary E Aronow; Grazyna Adamus; Mones Abu-Asab; Yujuan Wang; Chi-Chao Chan; Z Nicholas Zakov; Arun D Singh
Journal:  Surv Ophthalmol       Date:  2012-07-10       Impact factor: 6.048

3.  Pityriasis rosea associated with pegylated interferon alfa and ribavirin treatment in a patient with chronic hepatitis C.

Authors:  Rahmet Güner; Siran Keske; Imran Hasanoğlu; Mehmet Taşyaran
Journal:  Balkan Med J       Date:  2013-06-01       Impact factor: 2.021

4.  Vitiligo at Injection Site of PEG-IFN-α 2a in Two Patients with Chronic Hepatitis C: Case Report and Literature Review.

Authors:  V Arya; M Bansal; L Girard; S Arya; A Valluri
Journal:  Case Rep Dermatol       Date:  2010-08-27

5.  Vitiligo in a Patient Treated with Interferon Alpha-2a for Behçet's Disease.

Authors:  Esra Guney; Gulunay Akcali; Betul Ilkay Akcay; Cihan Unlu; Gurkan Erdogan; Tahir Kansu Bozkurt; Huseyin Bayramlar
Journal:  Case Rep Med       Date:  2012-08-16

Review 6.  Concise review of recent studies in vitiligo.

Authors:  Mohamed Allam; Hassan Riad
Journal:  Qatar Med J       Date:  2013-12-23

7.  Observational descriptive study of cutaneous manifestations in patients from Mato Grosso with viral chronic hepatitis.

Authors:  Renato Roberto Liberato Rostey; Francisco José Dutra Souto
Journal:  An Bras Dermatol       Date:  2015 Nov-Dec       Impact factor: 1.896

Review 8.  The Risk of Systemic Diseases in Those with Psoriasis and Psoriatic Arthritis: From Mechanisms to Clinic.

Authors:  Yu Ri Woo; Chul Jong Park; Hoon Kang; Jung Eun Kim
Journal:  Int J Mol Sci       Date:  2020-09-24       Impact factor: 5.923
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.